Norris Medicines Ltd.
Norris Medicines
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹14.25 Cr.
| EX-Date | Purpose |
|---|---|
| 28 06 2021 | Quarterly Results & Audited Results |
| 14 08 2021 | Quarterly Results |
| 12 11 2021 | Quarterly Results |
| 12 02 2022 | Quarterly Results |
| 25 05 2022 | Audited Results |
| 31 08 2022 | A.G.M. |
| 13 02 2023 | Quarterly Results |
| 25 05 2023 | Audited Results |
| 10 08 2023 | Quarterly Results |
| 10 11 2023 | Quarterly Results |
| 18 11 2023 | A.G.M. |
| 14 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 13 02 2025 | Quarterly Results Inter alia, to consider and approve :- 1. To consider and approve requests regarding from Mr. Nimish Bhishma Thakore, Promoter / Promoter Group for reclassification from Promoter / Promoter Group into Public Category to Public Category in accordance with the Regulation 31A of SEBI (LODR) Regulation 2015. 2. Any other business with the permission of Chair. |
| 28 05 2025 | Audited Results |
| 14 08 2025 | Quarterly Results |
| 14 11 2025 | Quarterly Results |
| 14 02 2026 | Quarterly Results |
No News data available
